Opportunity of Biopharma Networking during the “Connect-Bio: Médecine personnalisée” event in 22 days.
CQDM and Axelys invite you to this Connect-BIO event, bringing together passionate researchers and entrepreneurs in the field of personalized medicine. The first part of the event will consist of an overview of the perspectives and issues linked to the development and commercialization of innovations in personalized medicine, presented by the panelists:
-Michele D‘Elia, Roche Diagnostics
-Stéphane Gagné, Immugenia Inc.
-Anne Marinier, RejuvenRx
-Jean-François Haince, Solutions Biomark Diagnostics Inc
-Claude Perreault, IRIC
The event will be followed by a networking cocktail where you will be have the opportunity to networkwith the main players in the biopharma ecosystem and share your perspectives on personalized healthcare.
Let’s all meet on January 31, 2024, from 4:30 p.m., at the Grande Bibliothèque de BAnQ.
Registration required via this link:
https://www.eventbrite.com/e/billets-connect-bio-medecine-personnalisee-778458499327?aff=oddtdtcreator
Opportunity of Biopharma Networking during the “Connect-Bio: Médecine personnalisée” event in 22 days.

Related news

Our News
Glycovax Pharma, the National Research Council of Canada and the Université de Montréal, join forces to develop an innovative vaccine against the bacterium Pseudomonas aeruginosa (Pa), made possible through CQDM’s financial support

Our News
CQDM, IVADO, and two Quebec-based companies join forces to accelerate the diagnosis of pancreatic neuroendocrine tumors using artificial intelligence

Our News